Cargando…

Application Analysis of UPOINT System in Chinese Type III Prostatitis Patients: A Single Center Experience

OBJECTIVE: UPOINT clinical phenotype system was used to estimate the type III prostatitis patients. Put in the erectile dysfunction (ED) domain and analysis the ED domain's effect towards the UPOINT system. METHODS: A total of 126 patients with type III prostatitis were prospectively collected...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zhongxiao, Su, Xiaonan, Cai, Chengfeng, Wang, Zehua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9085319/
https://www.ncbi.nlm.nih.gov/pubmed/35547566
http://dx.doi.org/10.1155/2022/9227032
_version_ 1784703788388450304
author Zhang, Zhongxiao
Su, Xiaonan
Cai, Chengfeng
Wang, Zehua
author_facet Zhang, Zhongxiao
Su, Xiaonan
Cai, Chengfeng
Wang, Zehua
author_sort Zhang, Zhongxiao
collection PubMed
description OBJECTIVE: UPOINT clinical phenotype system was used to estimate the type III prostatitis patients. Put in the erectile dysfunction (ED) domain and analysis the ED domain's effect towards the UPOINT system. METHODS: A total of 126 patients with type III prostatitis were prospectively collected and classified in each domain of the UPOINT system, including urinary, psychosocial, organ-specific, infection, neurological/systemic, and tenderness. Symptom severity was measured using the national institutes of health chronic prostatitis symptom index (NIH-CPSI) and the international prostate symptom score (IPSS). The erectile function was evaluated using the international index of erectile function (IIEF-5). Mental state was evaluated using the Symptom Checklist 90 (SCL-90). The quality of life of patients was assessed by the Quality of Life scale (QoL). RESULTS: The percentage of patients positive for each domain was 60.32%, 43.65%, 53.17%, 11.11%, 42.06%, and 33.33% for the urinary, psychosocial, organ-specific, infection, neurological/systemic, and tenderness, respectively. There were significant correlations between the number of positive UPOINT domains and total NIH-CPSI (r = 0.630, P < 0.001) and IPSS (r = 0.429, P < 0.001). Symptom duration was associated with a number of positive domains (r = 0.194, P < 0.05). After adding an ED domain to establish a modified UPOINT system, the correlation between the number of positive domains and symptom severity was not improved (0.630 to 0.590, P < 0.001). The percentage of the patients who suffered psychosocial problems was 43.65%. CONCLUSIONS: In our cohort, the number of positive domains was correlated with symptom severity. Inclusion of the ED phenotype in the UPOINT phenotype classification system did not significantly enhance the association of positive presentation with symptom severity. Our findings presented do not support the utility of using ED as a stand-alone item in the UPOINT domain. Psychological problems should be considered when treating type III prostatitis patients.
format Online
Article
Text
id pubmed-9085319
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-90853192022-05-10 Application Analysis of UPOINT System in Chinese Type III Prostatitis Patients: A Single Center Experience Zhang, Zhongxiao Su, Xiaonan Cai, Chengfeng Wang, Zehua Comput Math Methods Med Research Article OBJECTIVE: UPOINT clinical phenotype system was used to estimate the type III prostatitis patients. Put in the erectile dysfunction (ED) domain and analysis the ED domain's effect towards the UPOINT system. METHODS: A total of 126 patients with type III prostatitis were prospectively collected and classified in each domain of the UPOINT system, including urinary, psychosocial, organ-specific, infection, neurological/systemic, and tenderness. Symptom severity was measured using the national institutes of health chronic prostatitis symptom index (NIH-CPSI) and the international prostate symptom score (IPSS). The erectile function was evaluated using the international index of erectile function (IIEF-5). Mental state was evaluated using the Symptom Checklist 90 (SCL-90). The quality of life of patients was assessed by the Quality of Life scale (QoL). RESULTS: The percentage of patients positive for each domain was 60.32%, 43.65%, 53.17%, 11.11%, 42.06%, and 33.33% for the urinary, psychosocial, organ-specific, infection, neurological/systemic, and tenderness, respectively. There were significant correlations between the number of positive UPOINT domains and total NIH-CPSI (r = 0.630, P < 0.001) and IPSS (r = 0.429, P < 0.001). Symptom duration was associated with a number of positive domains (r = 0.194, P < 0.05). After adding an ED domain to establish a modified UPOINT system, the correlation between the number of positive domains and symptom severity was not improved (0.630 to 0.590, P < 0.001). The percentage of the patients who suffered psychosocial problems was 43.65%. CONCLUSIONS: In our cohort, the number of positive domains was correlated with symptom severity. Inclusion of the ED phenotype in the UPOINT phenotype classification system did not significantly enhance the association of positive presentation with symptom severity. Our findings presented do not support the utility of using ED as a stand-alone item in the UPOINT domain. Psychological problems should be considered when treating type III prostatitis patients. Hindawi 2022-05-02 /pmc/articles/PMC9085319/ /pubmed/35547566 http://dx.doi.org/10.1155/2022/9227032 Text en Copyright © 2022 Zhongxiao Zhang et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Zhang, Zhongxiao
Su, Xiaonan
Cai, Chengfeng
Wang, Zehua
Application Analysis of UPOINT System in Chinese Type III Prostatitis Patients: A Single Center Experience
title Application Analysis of UPOINT System in Chinese Type III Prostatitis Patients: A Single Center Experience
title_full Application Analysis of UPOINT System in Chinese Type III Prostatitis Patients: A Single Center Experience
title_fullStr Application Analysis of UPOINT System in Chinese Type III Prostatitis Patients: A Single Center Experience
title_full_unstemmed Application Analysis of UPOINT System in Chinese Type III Prostatitis Patients: A Single Center Experience
title_short Application Analysis of UPOINT System in Chinese Type III Prostatitis Patients: A Single Center Experience
title_sort application analysis of upoint system in chinese type iii prostatitis patients: a single center experience
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9085319/
https://www.ncbi.nlm.nih.gov/pubmed/35547566
http://dx.doi.org/10.1155/2022/9227032
work_keys_str_mv AT zhangzhongxiao applicationanalysisofupointsysteminchinesetypeiiiprostatitispatientsasinglecenterexperience
AT suxiaonan applicationanalysisofupointsysteminchinesetypeiiiprostatitispatientsasinglecenterexperience
AT caichengfeng applicationanalysisofupointsysteminchinesetypeiiiprostatitispatientsasinglecenterexperience
AT wangzehua applicationanalysisofupointsysteminchinesetypeiiiprostatitispatientsasinglecenterexperience